 |
|
| Personal data sheet |
 Print previewVALIDITY EXPIRED
personal data approved: 2019. IV. 02. | Publications |
2018
 from data base, 2019. IV. 02. |
Sticz T, Molnar A, Danko T, Hujber Z, Petovari G, Nagy N, Vegso G, Kopper L, Sebestyen A: The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells, PATHOLOGY AND ONCOLOGY RESEARCH In press: p. In press.
type of document: Journal paper/Article
language: English
|
2017
from data base, 2019. IV. 02. |
Krencz I, Sebestyen A, Fabian K, Mark A, Moldvay J, Khoor A, Kopper L, Papay J: Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma., HUMAN PATHOLOGY 62: pp. 66-73.
type of document: Journal paper/Article
number of independent citations: 4
language: English
|
2017
from data base, 2019. IV. 02. |
Sticz T, Molnar A, Mark A, Hajdu M, Nagy N, Vegso G, Micsik T, Kopper L, Sebestyen A: mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression., JOURNAL OF CLINICAL PATHOLOGY 70: (5) pp. 410-416.
type of document: Journal paper/Article
number of independent citations: 5
language: English
|
2015
from data base, 2019. IV. 02. |
Sebestyén A, Márk A, Hajdu M, Nagy N, Molnár A, Végső G, Barna G, Kopper L: Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas, CYTOKINE 73: (2) pp. 219-224.
type of document: Journal paper/Article
number of independent citations: 6
language: English
|
2015
from data base, 2019. IV. 02. |
Karolina Nemes, Monika Csóka, Noémi Nagy, Ágnes Márk, Zsófia Váradi, Titanilla Dankó, Gábor Kovács, László Kopper, Anna Sebestyén: Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia, PATHOLOGY AND ONCOLOGY RESEARCH 21: (3) pp. 597-604.
type of document: Journal paper/Article
number of independent citations: 16
language: English
|
2013
from data base, 2019. IV. 02. |
Mark A, Hajdu M, Varadi Z, Sticz TB, Nagy N, Csomor J, Berczi L, Varga V, Csoka M, Kopper L, Sebestyen A: Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease - a combined tissue microarray, in vitro and in vivo study., BMC CANCER 13: 250
type of document: Journal paper/Article
number of independent citations: 18
language: English
URL |
2010
from data base, 2019. IV. 02. |
Petak I, Schwab R, Orfi L, Kopper L, Keri G: Integrating molecular diagnostics into anticancer drug discovery, NATURE REVIEWS DRUG DISCOVERY 9: (7) pp. 523-535.
type of document: Journal paper/Article
number of independent citations: 43
language: English
|
2003
from data base, 2019. IV. 02. |
Petak I, Danam RP, Tillman DM, Vernes R, Howell SR, Berczi L, Kopper L, Brent TP, Houghton JA: Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma, CELL DEATH AND DIFFERENTIATION 10: (2) pp. 211-217.
type of document: Journal paper/Article
number of independent citations: 62
language: English
|
1999
from data base, 2019. IV. 02. |
Sebestyen A, Berczi L, Mihalik R, Paku S, Matolcsy A, Kopper L: Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas, BRITISH JOURNAL OF HAEMATOLOGY 104: (2) pp. 412-419.
type of document: Journal paper/Article
number of independent citations: 42
language: English
|
1988
from data base, 2019. IV. 02. |
Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential, JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 80: pp. 200-204.
type of document: Journal paper/Article
number of independent citations: 1123
language: English
|
| | Number of independent citations to these publications: | 1319 |
|
|
|
|
|
Login
